Mastek reports Q2 FY26 consolidated revenue growth; net profit and EPS decline
Mastek reported Q2 FY26 consolidated revenue growth to ₹940.37 crore, but net profit fell to ₹97.45 crore from ₹128.65 crore in Q2 FY25. EPS also declined.
Financial results are a primary indicator of a company's health and directly influence investor sentiment and stock valuation, making this a high-impact announcement.
Consolidated revenue grew year-on-year, but net profit and EPS declined significantly for both the quarter and half-year, indicating mixed financial performance.
* Mastek Limited's Board of Directors approved the unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2025, at their meeting held on October 16, 2025. * For the quarter ended September 30, 2025, consolidated revenue from operations increased to ₹94,037 lakhs (₹940.37 crore) from ₹86,739 lakhs (₹867.39 crore) in the corresponding quarter of the previous year. * However, consolidated net profit for the quarter declined to ₹9,745 lakhs (₹97.45 crore) compared to ₹12,865 lakhs (₹128.65 crore) in Q2 FY25. * Consolidated basic Earnings Per Share (EPS) for Q2 FY26 was ₹31.48, a decrease from ₹41.69 in Q2 FY25. * For the six months ended September 30, 2025, consolidated revenue from operations grew to ₹185,507 lakhs (₹1,855.07 crore), while net profit decreased to ₹18,950 lakhs (₹189.50 crore) from ₹20,015 lakhs (₹200.15 crore) in the prior year. * Segment-wise, UK & Europe operations reported significant revenue growth, reaching ₹60,622 lakhs (₹606.22 crore) in Q2 FY26 from ₹48,508 lakhs (₹485.08 crore) in Q2 FY25. North America and AMEA operations experienced declines. * The company recognized a loss of ₹1,090 lakhs (₹10.90 crore) on the fair value change of an investment in Volteo Edge, which was recorded in Other Comprehensive Income. * The paid-up equity share capital increased by ₹1.7 lakhs due to the allotment of 34,823 equity shares upon the exercise of options under ESOP schemes.
What to do with a filing like this
Mastek Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.